Cutaneous Vasculitis in a Patient with Dermatomyositis without Muscle Involvement.

Kadoya, Akifumi; Akahoshi, Tohru; Sekiyama, Naho; Hosaka, Shigeru; Kondo, Hirobumi

doi:10.2169/internalmedicine.33.809

Cited by 11 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is rarely reported in adults but common in the juvenile form. 2 Feldman et al 3,4 have reported that 9% of 76 patients with adult DM had cutaneous vasculitis. Current evidence suggests that DM may be a humorally mediated disease; hence, it seems to be responsive to drugs that target the B cells like rituximab (antiYCD20 chimeric monoclonal mouse/ human antibody).…”

Section: Discussionmentioning

confidence: 99%

Successful Use of Rituximab in Recalcitrant Skin Predominant Dermatomyositis

Joshi¹,

Nautiyal

Davies

2011

JCR: Journal of Clinical Rheumatology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Successful Use of Rituximab in Recalcitrant Skin Predominant Dermatomyositis

Joshi¹,

Nautiyal

Davies

2011

JCR: Journal of Clinical Rheumatology

View full text Add to dashboard Cite

“…Vasculitis over the course of SSc is a rarely observed, mostly as part of the limited scleroderma pattern and is associated with the presence of anti-centromere antibodies [23,24]. Only a few descriptions of cutaneous vasculitis with periungual infarcts and digital ulcerations are reported in the literature in the context of idiopathic inflammatory myopathies [25,26]. In our study, we also noted only a small number of such cases.…”

Section: Discussionmentioning

confidence: 53%

Structure of the vasculitides observed in the Clinic of Rheumatology

Yoneva¹,

Zdravkova²,

Kotov³

et al. 2020

BRJ

View full text Add to dashboard Cite

Systemic vasculitides are a heterogenic group of disorders characterized by destructive inflammation and fibrinoid necrosis of the vascular wall, vessel occlusion and tissue ischemia. Vasculitides presenting with necrosis are included in neither of the contemporary classifications, even though this type of vascular pathology is the one with the most dramatic manifestations in rheumatology. There have been no analyses of the nosological association, clinical features and therapeutic management of the vasculitides with necrosis in the pertinent literature. The aim of the present study was to analyze vasculitides in the Bulgarian population in terms of their nosological association; to examine the portion that ANCA-associated vasculitides represent out of all vasculitic syndromes on the one hand, and to make an analysis of the vasculitides with necrosis according to their nosological association on the other. In the present study, we included 388 patients with vasculitis, 251 of whom were female and 137 male. We conducted a prospective and retrospective analysis which covered the patients with vasculitis who were admitted to the Clinic of Rheumatology over the period 2009-2018. ANCA-associated vasculitides were the most often diagnosed vasculitides in the Clinic of Rheumatology. Vasculitic manifestations over the course of connective tissue diseases (most often systemic lupus erythematosus and systemic sclerosis) were the second most common group. Life-threatening cases of vasculitis with necrosis were mainly the result of flares of different connective tissue diseases. The major necrotizing vasculitides (Wegener’s granulomatosis and microscopic polyangiitis) were responsible for 12.6% of the cases of vasculitis with necrosis. In order to establish the correct diagnosis and start the suitable treatment, it is of vital importance to recognize the different vasculitic syndromes and their wide differential diagnosis. Most of them respond well to the currently available therapeutic options, especially if the correct diagnosis has been established early.

show abstract

Vasculitis in the Idiopathic Inflammatory Myopathies

Miller

Oddis

2012

Inflammatory Diseases of Blood Vessels

View full text Add to dashboard Cite

Cutaneous Vasculitis in a Patient with Dermatomyositis without Muscle Involvement.

Cited by 11 publications

References 5 publications

Successful Use of Rituximab in Recalcitrant Skin Predominant Dermatomyositis

Successful Use of Rituximab in Recalcitrant Skin Predominant Dermatomyositis

Structure of the vasculitides observed in the Clinic of Rheumatology

Vasculitis in the Idiopathic Inflammatory Myopathies

Contact Info

Product

Resources

About